BLK
BlackRock, Inc.
BLK's fundamentals are mixed, but it looks expensive: trading at 28x earnings, above its usual 22x.
MCHB
Mechanics Bank
There isn't enough reported data to score MCHB yet.
BLK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BLK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BLK.
MCHB Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Stable | |
| N/A | |
| N/A |
MCHB's profitability is currently stable. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like MCHB.
BLK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 19x | $848 | -30% |
| Fair | 22x | $973 | -20% |
| Expensive | 26x | $1,149 | -5.5% |
| Current | 28x | $1,217 | — |
Historical ranges are pointers, not guarantees.
BLK's PE is in its expensive range at 28x.
MCHB PE Valuation
MCHB has no meaningful PE right now: it lost money over the past year.
BLK Forward outlook
There aren't enough analyst estimates for BLK to show an outlook.
MCHB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect MCHB's revenue to grow, with its earnings and profitability holding steady.
BLK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $43.87 | +11% |
| Q2 2026 | $41.73 | -0.4% |
| Q1 2026 | $39.73 | -4.7% |
| Q4 2025 | $35.31 | -17% |
| Q3 2025 | $39.42 | -2.7% |
| Q2 2025 | $41.89 | +4% |
| Q1 2025 | $41.69 | +5.9% |
| Q4 2024 | $42.53 | +16% |
BLK has the stronger earnings trend. Trailing diluted EPS is up 11% for BLK versus MCHB down 259%.
MCHB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.07 | — |
| Q3 2024 | -$1.30 | -$0.48 |
| Q2 2024 | -$0.79 | -664% |
| Q1 2024 | -$2.13 | -177% |
| Q4 2023 | -$1.46 | -142% |
| Q3 2023 | -$0.82 | -118% |
| Q2 2023 | $0.14 | -97% |
| Q1 2023 | $2.75 | -46% |
| Q4 2022 | $3.49 | -36% |
MCHB lost $1.30 per share over the past year, a bigger loss than the year before.
BLK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.8B | +19% |
| Q2 2026 | $7.1B | +31% |
| Q1 2026 | $6.7B | +27% |
| Q4 2025 | $7B | +23% |
| Q3 2025 | $6.5B | +25% |
| Q2 2025 | $5.4B | +13% |
| Q1 2025 | $5.3B | +12% |
| Q4 2024 | $5.7B | +23% |
BLK has the edge over MCHB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | 0 points |
| Q2 2026 | 35% | +2.8 points |
| Q1 2026 | 42% | +9.8 points |
| Q4 2025 | 24% | -13 points |
| Q3 2025 | 30% | -8.6 points |
| Q2 2025 | 32% | -5.5 points |
| Q1 2025 | 32% | -3.6 points |
| Q4 2024 | 37% | +2.3 points |
BLK's operating margin was 30% last quarter, about level with the same quarter a year ago, near the bottom of its range since 2019.
MCHB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $161.5M | -37% |
| Q2 2026 | $201M | +310% |
| Q1 2026 | $200.1M | +341% |
| Q3 2025 | $255.4M | +544% |
| Q2 2025 | $49M | +14% |
| Q1 2025 | $45.4M | +9% |
| Q3 2024 | $39.7M | -20% |
| Q2 2024 | $42.9M | -20% |
MCHB's revenue is growing: $161M last quarter, down 37% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 39% | +21 points |
| Q2 2026 | 39% | +49 points |
| Q1 2026 | 31% | +41 points |
| Q4 2025 | 59% | N/A |
| Q3 2025 | 18% | +42 points |
| Q2 2025 | -9.8% | +8.9 points |
| Q1 2025 | -10% | +15 points |
| Q3 2024 | -24% | -27 points |
MCHB has the edge over BLK on profitability, with a higher operating margin.
BLK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.6B | +95% |
| Q2 2026 | $1.1B | -12% |
| Q1 2026 | -$1.1B | +$120M |
| Q4 2025 | $2.1B | -15% |
| Q2 2025 | $1.3B | -6.1% |
| Q1 2025 | -$1.2B | -$734M |
| Q4 2024 | $2.5B | +35% |
| Q2 2024 | $1.4B | +47% |
BLK has the edge over MCHB on cash flow, with more consistent year-over-year improvement.
MCHB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26.4M | -76% |
| Q2 2026 | $49.6M | +$59.5M |
| Q1 2026 | $8.8M | +$31.3M |
| Q3 2025 | $109.1M | +$126.6M |
| Q2 2025 | -$9.9M | +$12.2M |
| Q1 2025 | -$22.6M | -$8.7M |
| Q3 2024 | -$17.5M | -161% |
| Q2 2024 | -$22M | -213% |
MCHB's free cash flow was $195M over the past year, about three times what it generated the year before. Free cash flow isn't a meaningful measure for financial services companies like MCHB.
BLK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -148K shares |
| 1 year | -0.4% | -677K shares |
| 3 years | +9.3% | +14M shares |
| 5 years | +6.2% | +9.6M shares |
| Available history | +4.4% | +7M shares |
BLK has the edge over MCHB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | $396M |
| Q1 2025 | $657M |
| Q4 2024 | $386M |
| Q2 2024 | $519M |
| Q1 2024 | $634M |
| Q4 2023 | $384M |
| Q3 2023 | $396M |
| Q2 2023 | $383M |
MCHB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +0.3% | +63.9K shares |
| 3 years | -4.4% | -871K shares |
| 5 years | -21% | -4.9M shares |
MCHB has 19M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | $75M |
BLK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.0x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2024 | 0.2x | Very low |
| Q1 2024 | 0.3x | Very low |
| Q4 2023 | 0.1x | Very low |
BLK has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like BLK.
MCHB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.2x | Net Cash |
| Q2 2023 | 128.7x | High |
| Q1 2023 | 22.9x | High |
| Q4 2022 | 12.4x | High |
| Q3 2022 | 14.3x | High |
| Q2 2022 | 12.4x | High |
| Q1 2022 | 2.9x | Moderate |
| Q4 2021 | 0.7x | Very low |
MCHB has the edge over BLK on leverage, with a lower net debt burden relative to earnings.
BLK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.5 | Neutral |
| Stochastic | 79.0 | Neutral |
BLK's weekly RSI is 64 (neutral) and its Stochastic is 79 (neutral).
MCHB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.5 | Neutral |
| Stochastic | 16.7 | Oversold |
MCHB's weekly RSI is 42 (neutral) and its Stochastic is 17 (oversold).
BLK PE vs Financial Services Sector
| Metric | BLK | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 13x | 113% above |
| PE % | 97 | 63 | 34 pts above |
BLK is trading at 28x earnings, a 113% premium to the Financial Services sector's median of 13x.
MCHB PE vs Financial Services Sector
| Metric | MCHB | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
MCHB has no meaningful PE right now: it lost money over the past year.
BLK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,128.0 | 7.9% above |
| 20 week MA | $1,108.9 | 9.7% above |
| 50 week MA | $1,071.6 | 14% above |
| 100 week MA | $1,051.1 | 16% above |
| 200 week MA | $914.1 | 33% above |
BLK has the edge over MCHB on trend strength, trading above more of its moving averages.
MCHB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.7 | 2.2% below |
| 20 week MA | $15.6 | 7.5% below |
| 50 week MA | $15.2 | 5.1% below |
| 100 week MA | $13.6 | 5.7% above |
| 200 week MA | $13.0 | 11% above |
MCHB has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 11% above its 200-week average.
BLK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $503.0 | $707.2 | +41% |
| 2021 | $707.2 | $913.9 | +29% |
| 2022 | $913.9 | $703.9 | -23% |
| 2023 | $703.9 | $811.8 | +15% |
| 2024 | $811.8 | $1,044.2 | +29% |
| 2025 | $1,044.2 | $1,088.1 | +4.2% |
| 2026 YTD | $1,088.1 | $1,216.6 | +12% |
BLK has the edge over MCHB on returns for 2026, with the stronger performance.
MCHB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $33.9 | $33.5 | -0.9% |
| 2021 | $33.5 | $51.4 | +53% |
| 2022 | $51.4 | $27.0 | -47% |
| 2023 | $27.0 | $10.3 | -62% |
| 2024 | $10.3 | $11.2 | +8.3% |
| 2025 | $11.2 | $14.7 | +31% |
| 2026 YTD | $14.7 | $14.4 | -2% |
MCHB has finished lower in three of the last six years. It's down 2% so far in 2026.